Answers are grounded in this paper and cite their sources.
Flumazenil (Anexate®, Roche, Basel, Switzerland) is a specific, high-affinity, competitive inhibitor of the central nervous system's benzodiazepine γ-aminobutyric acid receptor, with high clinical efficacy in reversing the effects of benzodiazepine overdose (1, 2). Flumazenil is used in the emergency room in the diagnosis and treatment of coma of unknown etiology, when benzodiazepine overdose is suspected (3, 4). Flumazenil is a relatively safe drug, with rare side-effects, such as agitation, anxiety, allergic reaction, and arrhythmia (5). We describe a patient who developed a grand-mal seizure after flumazenil administration.
No takes yet. Share an insight, caveat, or question.
Mordel et al. (1992) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: